KORU Medical Systems, Inc. Financial Summary

Quick Answer

KORU Medical Systems, Inc. reported Total Revenue of $41.13 million for fiscal year 2025.

KORU Medical Systems, Inc. — Key Financials by Year

Metric 2025 2024 2023 2022 2021 2020
Total Revenue $41.13M
+22.2%
$33.65M
+18.0%
$28.52M
+2.2%
$27.90M
+18.8%
$23.49M
-2.8%
$24.18M
+4.4%
Net Income -$2.64M
+56.5%
-$6.07M
+55.9%
-$13.74M
-58.7%
-$8.66M
-89.8%
-$4.56M
-276.5%
-$1.21M
-314.8%
Diluted EPS -$0.06
+53.8%
-$0.13
+56.7%
-$0.30
-57.9%
-$0.19
-90.0%
-$0.10
-233.3%
-$0.03
-400.0%
Total Assets $28.20M
+3.6%
$27.22M
-4.4%
$28.46M
-32.8%
$42.33M
+2.5%
$41.29M
+3.4%
$39.92M
+187.6%
Cash and Equivalents $8.87M
-7.4%
$9.58M
-16.6%
$11.48M
-34.0%
$17.41M
-31.3%
$25.33M
-7.3%
$27.32M
+365.3%
Stockholders Equity $17.05M
+1.4%
$16.81M
-17.4%
$20.35M
-35.0%
$31.33M
-14.2%
$36.50M
+1.0%
$36.16M
+221.8%
R&D Expense $4.39M
-16.6%
$5.26M
-8.4%
$5.74M
+15.9%
$4.96M
+100.4%
$2.47M
+90.8%
$1.30M
+75.1%
Operating Income -$2.97M
+53.9%
-$6.45M
+37.2%
-$10.27M
+4.7%
-$10.78M
-53.4%
-$7.03M
-460.2%
-$1.25M
-314.2%
Gross Profit $25.60M
+20.0%
$21.33M
+27.7%
$16.71M
+8.7%
$15.37M
+11.6%
$13.77M
-7.8%
$14.94M
+0.6%
Shares Outstanding 46.37M
+0.9%
45.96M
+0.6%
45.67M
+0.5%
45.44M
+1.8%
44.62M
+3.2%
43.26M
+9.5%

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue September 30, 2025 $10.40M +27.2% +2.0%
Net Income September 30, 2025 -$778.0K +50.8% -276.1%
Diluted EPS September 30, 2025 $0.02 -33.3%
Total Assets September 30, 2025 $27.10M -1.0% +6.2%
Cash and Equivalents September 30, 2025 $8.46M -3.9% +5.1%
Stockholders Equity September 30, 2025 $16.46M -7.2% -0.4%
R&D Expense September 30, 2025 $933.1K -39.2% -21.9%
Operating Income September 30, 2025 -$867.7K +49.1% -177.5%
Gross Profit September 30, 2025 $6.26M +20.8% -3.3%
Shares Outstanding September 30, 2025 46.29M +1.0% +0.1%
  • KORU Medical Systems, Inc. reported Total Revenue of $41.13 million for fiscal year 2025.
  • KORU Medical Systems, Inc. showed an increase of +22.2% in Total Revenue compared to the prior fiscal year.
  • KORU Medical Systems, Inc. reported Net Income of -$2.64 million for fiscal year 2025.
  • KORU Medical Systems, Inc. showed an increase of +56.5% in Net Income compared to the prior fiscal year.
  • KORU Medical Systems, Inc. reported Diluted EPS of $0.06 per share (loss) for fiscal year 2025.
  • KORU Medical Systems, Inc. showed an increase of +53.8% in Diluted EPS compared to the prior fiscal year.
  • KORU Medical Systems, Inc. reported Total Assets of $28.20 million for fiscal year 2025.
  • KORU Medical Systems, Inc. showed an increase of +3.6% in Total Assets compared to the prior fiscal year.
  • KORU Medical Systems, Inc. reported Cash and Equivalents of $8.87 million for fiscal year 2025.
  • KORU Medical Systems, Inc. showed a decrease of -7.4% in Cash and Equivalents compared to the prior fiscal year.
  • KORU Medical Systems, Inc. reported Stockholders Equity of $17.05 million for fiscal year 2025.
  • KORU Medical Systems, Inc. showed an increase of +1.4% in Stockholders Equity compared to the prior fiscal year.
  • KORU Medical Systems, Inc. reported R&D Expense of $4.39 million for fiscal year 2025.
  • KORU Medical Systems, Inc. showed a decrease of -16.6% in R&D Expense compared to the prior fiscal year.
  • KORU Medical Systems, Inc. reported Operating Income of -$2.97 million for fiscal year 2025.
  • KORU Medical Systems, Inc. showed an increase of +53.9% in Operating Income compared to the prior fiscal year.
  • KORU Medical Systems, Inc. reported Gross Profit of $25.60 million for fiscal year 2025.
  • KORU Medical Systems, Inc. showed an increase of +20.0% in Gross Profit compared to the prior fiscal year.
  • KORU Medical Systems, Inc. reported Shares Outstanding of 46.37 million shares for fiscal year 2025.
  • KORU Medical Systems, Inc. showed an increase of +0.9% in Shares Outstanding compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment